INS and type 2 diabetes mellitus: Patients with Type 2 diabetes Mellitus may inadequately control on oral antidiabetic drugs when they are put on twelve weeks of insulin glargine therapy having hepatic fat reduction on MRS by 12.6 % to 9.9% with an improvement in HbA1c from 7.9% to 7.2%.